Hy2Care

Hy2Care

Hy2Care

Hy2Care develops in situ gelating bioresorbable hydrogels for the arthroscopic treatment of cartilage defects, aiming at functional cartilage repair.
Founded
2014
Raised
$4.2M
Follow us
Alexa global traffic share
01 May 2019
€3,700,000
Venture capital (Series A)
ReumaNederland, Brightlands Venture Partners
31 Mar 2015
$16,227
Seed fund